- Home
- XPEV vs NBIX Comparison
XPEV vs NBIX Comparison
Compare XPEV & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPEV
- NBIX
- Stock Information
- Founded
- XPEV 2015
- NBIX 1992
- Country
- XPEV China
- NBIX United States
- Employees
- XPEV N/A
- NBIX N/A
- Industry
- XPEV Auto Manufacturing
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XPEV Consumer Discretionary
- NBIX Health Care
- Exchange
- XPEV Nasdaq
- NBIX Nasdaq
- Market Cap
- XPEV 12.0B
- NBIX 11.0B
- IPO Year
- XPEV 2020
- NBIX 1996
- Fundamental
- Price
- XPEV $19.54
- NBIX $118.76
- Analyst Decision
- XPEV Buy
- NBIX Strong Buy
- Analyst Count
- XPEV 8
- NBIX 20
- Target Price
- XPEV $21.71
- NBIX $163.20
- AVG Volume (30 Days)
- XPEV 8.4M
- NBIX 1.9M
- Earning Date
- XPEV 05-20-2025
- NBIX 05-05-2025
- Dividend Yield
- XPEV N/A
- NBIX N/A
- EPS Growth
- XPEV N/A
- NBIX N/A
- EPS
- XPEV N/A
- NBIX 2.96
- Revenue
- XPEV $5,598,814,778.00
- NBIX $2,412,600,000.00
- Revenue This Year
- XPEV $99.59
- NBIX $15.36
- Revenue Next Year
- XPEV $35.36
- NBIX $16.34
- P/E Ratio
- XPEV N/A
- NBIX $39.74
- Revenue Growth
- XPEV 33.22
- NBIX 21.73
- 52 Week Low
- XPEV $6.60
- NBIX $84.23
- 52 Week High
- XPEV $27.16
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- XPEV 49.44
- NBIX 65.56
- Support Level
- XPEV $19.08
- NBIX $105.45
- Resistance Level
- XPEV $20.04
- NBIX $130.46
- Average True Range (ATR)
- XPEV 0.55
- NBIX 4.16
- MACD
- XPEV 0.07
- NBIX 2.16
- Stochastic Oscillator
- XPEV 45.18
- NBIX 60.66
About XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 141,000 EVs in 2023, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.